Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy

por Zuqiang Liu, Roshni Ravindranathan, Pawel Kalinski, Z. Sheng Guo, David L. Bartlett
Publicado 2017

Modifying the cancer-immune set point using vaccinia virus expressing re-designed interleukin-2

por Zuqiang Liu, Yan Ge, Haiyan Wang, Congrong Ma, Mathilde Feist, Songguang Ju, Z. Sheng Guo, David L. Bartlett
Publicado 2018

INTRAPLEURAL THERAPY TO DRIVE SYSTEMIC ANTI-TUMOR IMMUNITY

por Vera S. Donnenberg, PhD, FCP, James D. Luketich, MD, David L. Bartlett, MD, Albert D. Donnenberg, PhD
Publicado 2021

Suppressive IL-17A+Foxp3+ and ex-Th17 IL-17AnegFoxp3+ Treg cells are a source of tumour-associated Treg cells

por Stephanie Downs-Canner, Sara Berkey, Greg M. Delgoffe, Robert P. Edwards, Tyler Curiel, Kunle Odunsi, David L. Bartlett, Nataša Obermajer
Publicado 2017